STERIS plc (STE) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Medical - Devices
EV/EBITDA
↓
17.15
↓-16% vs avg
5yr avg: 20.45
30Y Low5.6·High25.9
P/FCF
↓
27.00
↓-36% vs avg
5yr avg: 42.00
30Y Low9.8·High59.8
P/B Ratio
↓
3.20
↓-11% vs avg
5yr avg: 3.58
30Y Low1.7·High5.2
ROE
↓
9.5%
↓+45% vs avg
5yr avg: 6.6%
30Y Low-10%·High23%
Debt/EBITDA
↓
1.64
↓-32% vs avg
5yr avg: 2.40
30Y Low0.4·High4.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
STE Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
STERIS plc trades at 34.5x earnings, 58% below its 5-year average of 82.6x, sitting at the 61st percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a premium of 54%. On a free-cash-flow basis, the stock trades at 27.0x P/FCF, 36% below the 5-year average of 42.0x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $21.0B | $22.5B | $22.3B | $19.2B | $23.8B | $16.4B | $12.0B | $10.9B | $8.0B | $6.0B | $5.1B |
| Enterprise Value | $23.0B | $24.5B | $25.5B | $22.2B | $26.7B | $17.9B | $13.0B | $11.9B | $9.1B | $7.2B | $6.4B |
| P/E Ratio → | 34.46 | 36.56 | 59.01 | 178.77 | 97.49 | 41.14 | 29.41 | 35.96 | 27.54 | 54.27 | 45.54 |
| P/S Ratio | 3.85 | 4.11 | 4.35 | 4.23 | 5.63 | 5.27 | 3.95 | 3.93 | 3.05 | 2.29 | 2.26 |
| P/B Ratio | 3.20 | 3.39 | 3.54 | 3.15 | 3.63 | 4.20 | 3.51 | 3.43 | 2.49 | 2.13 | 1.66 |
| P/FCF | 27.00 | 28.86 | 36.44 | 48.55 | 59.84 | 36.33 | 31.88 | 31.28 | 27.39 | 23.81 | 39.43 |
| P/OCF | 18.30 | 19.56 | 22.95 | 25.33 | 34.71 | 23.73 | 20.30 | 20.28 | 17.49 | 14.10 | 19.86 |
P/E links to full P/E history page with 30-year chart
STE EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
STERIS plc's enterprise value stands at 17.2x EBITDA, 16% below its 5-year average of 20.4x. The Healthcare sector median is 14.4x, placing the stock at a 19% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.48 | 4.97 | 4.90 | 6.32 | 5.77 | 4.27 | 4.28 | 3.48 | 2.75 | 2.85 |
| EV / EBITDA | 17.15 | 18.23 | 18.21 | 16.53 | 25.90 | 23.38 | 17.64 | 18.69 | 15.77 | 17.32 | 17.88 |
| EV / EBIT | 26.58 | 27.75 | 30.12 | 28.08 | 58.52 | 32.35 | 24.03 | 28.75 | 22.48 | 31.31 | 29.71 |
| EV / FCF | — | 31.47 | 41.63 | 56.24 | 67.22 | 39.84 | 34.44 | 34.03 | 31.20 | 28.57 | 49.71 |
STE Profitability
Margins and return-on-capital ratios measuring operating efficiency
STERIS plc earns an operating margin of 15.9%. Operating margins have compressed from 17.4% to 15.9% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 9.5% is modest. ROIC of 7.2% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.0% | 44.0% | 43.2% | 43.7% | 44.6% | 43.2% | 43.6% | 42.2% | 41.7% | 39.3% | 40.0% |
| Operating Margin | 15.9% | 15.9% | 16.3% | 17.4% | 11.3% | 17.6% | 17.7% | 14.8% | 15.3% | 8.7% | 9.5% |
| Net Profit Margin | 11.3% | 11.3% | 7.4% | 2.4% | 5.8% | 12.8% | 13.5% | 10.9% | 11.1% | 4.2% | 4.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.5% | 9.5% | 6.1% | 1.7% | 4.7% | 10.9% | 12.3% | 9.5% | 9.7% | 3.8% | 5.4% |
| ROA | 5.8% | 5.8% | 3.5% | 1.0% | 2.7% | 6.6% | 7.8% | 5.9% | 5.7% | 2.1% | 3.0% |
| ROIC | 7.2% | 7.2% | 6.7% | 6.4% | 4.8% | 8.3% | 9.4% | 7.3% | 7.2% | 4.1% | 5.4% |
| ROCE | 9.0% | 9.0% | 8.3% | 7.7% | 5.8% | 10.0% | 11.3% | 8.7% | 8.6% | 4.8% | 6.3% |
STE Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
STERIS plc carries a Debt/EBITDA ratio of 1.6x, which is manageable (50% below the sector average of 3.3x). Net debt stands at $2.0B ($2.2B total debt minus $172M cash). Interest coverage of 10.0x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.33 | 0.33 | 0.54 | 0.53 | 0.50 | 0.46 | 0.38 | 0.37 | 0.41 | 0.53 | 0.52 |
| Debt / EBITDA | 1.64 | 1.64 | 2.41 | 2.42 | 3.18 | 2.35 | 1.75 | 1.86 | 2.28 | 3.57 | 4.40 |
| Net Debt / Equity | — | 0.31 | 0.50 | 0.50 | 0.45 | 0.41 | 0.28 | 0.30 | 0.35 | 0.43 | 0.43 |
| Net Debt / EBITDA | 1.51 | 1.51 | 2.27 | 2.26 | 2.84 | 2.06 | 1.31 | 1.51 | 1.93 | 2.89 | 3.70 |
| Debt / FCF | — | 2.61 | 5.18 | 7.70 | 7.38 | 3.51 | 2.57 | 2.75 | 3.81 | 4.76 | 10.28 |
| Interest Coverage | 10.05 | 10.05 | 5.79 | 7.14 | 5.34 | 14.75 | 13.33 | 9.13 | 7.90 | 5.08 | 4.99 |
STE Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.96x means STERIS plc can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 1.39x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 2.33x to 1.96x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.96 | 1.96 | 3.08 | 2.33 | 2.04 | 2.10 | 2.43 | 2.27 | 2.48 | 2.67 | 2.43 |
| Quick Ratio | 1.39 | 1.39 | 2.36 | 1.63 | 1.41 | 1.55 | 1.91 | 1.82 | 1.97 | 2.15 | 1.95 |
| Cash Ratio | 0.17 | 0.17 | 0.22 | 0.24 | 0.38 | 0.38 | 0.63 | 0.47 | 0.51 | 0.74 | 0.62 |
| Asset Turnover | — | 0.54 | 0.46 | 0.42 | 0.37 | 0.47 | 0.56 | 0.55 | 0.50 | 0.53 | 0.42 |
| Inventory Turnover | 5.26 | 5.26 | 4.33 | 4.23 | 4.07 | 5.60 | 6.49 | 7.72 | 7.42 | 8.02 | 6.97 |
| Days Sales Outstanding | — | 69.79 | 71.62 | 69.60 | 69.06 | 71.58 | 70.63 | 74.10 | 73.57 | 67.54 | 76.88 |
STE Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
STERIS plc returns 2.0% to shareholders annually — split between a 1.0% dividend yield and 1.0% buyback yield. The payout ratio of 35.8% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 2.9% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.0% | 1.0% | 0.9% | 1.0% | 0.7% | 0.8% | 1.0% | 1.0% | 1.3% | 1.6% | 1.3% |
| Payout Ratio | 35.8% | 35.8% | 53.0% | 171.4% | 66.9% | 33.7% | 30.2% | 37.0% | 35.4% | 84.7% | 58.9% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.9% | 2.7% | 1.7% | 0.6% | 1.0% | 2.4% | 3.4% | 2.8% | 3.6% | 1.8% | 2.2% |
| FCF Yield | 3.7% | 3.5% | 2.7% | 2.1% | 1.7% | 2.8% | 3.1% | 3.2% | 3.7% | 4.2% | 2.5% |
| Buyback Yield | 1.0% | 0.9% | 0.1% | 1.6% | 0.2% | 0.1% | 0.4% | 0.7% | 0.8% | 1.6% | 0.3% |
| Total Shareholder Yield | 2.0% | 1.9% | 1.0% | 2.6% | 0.9% | 0.9% | 1.5% | 1.8% | 2.1% | 3.2% | 1.6% |
| Shares Outstanding | — | $99M | $99M | $100M | $98M | $86M | $86M | $85M | $86M | $86M | $71M |
Peer Comparison
Compare STE with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 STEYou | $21B | 34.5 | 17.2 | 27.0 | 44.0% | 15.9% | 9.5% | 7.2% | 1.6 |
 WAT | $23B | 32.6 | 21.5 | 42.3 | 57.8% | 28.2% | 29.3% | 20.3% | 1.3 |
 MMSI | $4B | 29.3 | 13.1 | 17.2 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 |
 HSIC | $8B | 21.6 | 10.9 | 14.1 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 |
 IART | $1B | -2.0 | 13.0 | — | 51.7% | 4.2% | -39.9% | 1.7% | 9.3 |
 CNMD | $1B | 25.2 | 10.2 | 7.8 | 52.8% | 10.3% | 4.7% | 5.8% | 4.3 |
 SHC | $4B | 58.0 | 21.1 | 30.0 | 55.5% | 33.8% | 15.4% | 11.8% | 7.5 |
 BDX | $56B | 26.3 | 14.7 | 20.8 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 |
 BAX | $9B | -10.0 | 25.4 | 28.0 | 30.1% | -2.7% | -14.6% | -1.4% | 14.9 |
 GEHC | $28B | 13.5 | 10.0 | 18.5 | 40.0% | 13.4% | 21.6% | 13.3% | 3.0 |
 MMM | $75B | 24.0 | 15.2 | 53.7 | 39.6% | 18.3% | 75.2% | 28.1% | 2.4 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Full STE Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See STE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs STE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare STE vs WAT
Side-by-side business, growth, and profitability comparison vs Waters Corporation.
Start ComparisonSTE — Frequently Asked Questions
Quick answers to the most common questions about buying STE stock.
What is STERIS plc's P/E ratio?
STERIS plc's current P/E ratio is 34.5x. The historical average is 38.9x. This places it at the 61th percentile of its historical range.
What is STERIS plc's EV/EBITDA?
STERIS plc's current EV/EBITDA is 17.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.4x.
What is STERIS plc's ROE?
STERIS plc's return on equity (ROE) is 9.5%. The historical average is 10.5%.
Is STE stock overvalued?
Based on historical data, STERIS plc is trading at a P/E of 34.5x. This is at the 61th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is STERIS plc's dividend yield?
STERIS plc's current dividend yield is 1.04% with a payout ratio of 35.8%.
What are STERIS plc's profit margins?
STERIS plc has 44.0% gross margin and 15.9% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does STERIS plc have?
STERIS plc's Debt/EBITDA ratio is 1.6x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.